Author:
Darnaud Nicolas,Mory Jean-Eudes,Romy Pascal,Berger Jacques,Eve Karine,Lantheaume Sophie
Abstract
Abstract
Introduction
This study investigated the perceptions and feelings of a French sample about the possible introduction of lung cancer screening.
Methods
A total of 146 individuals, aged between 19- and 64-years, participated in this study conducted between November 2020 and January 2021. Participants were divided into three groups according to their smoking status: (i) active smokers (G1); former smokers (G2); and non-smokers (G3). Each individual completed an online questionnaire evaluating their perceptions and feelings about lung cancer, screening and scans.
Results
Overall, a higher percentage of former smokers (47%) indicated a greater willingness to participate in lung cancer screening compared to active smokers (19%) and non-smokers (32%). Active smokers and former smokers reported anxiety about the development of lung cancer. Active smokers who wished to participate in screening reported a greater motivation to reduce their tobacco consumption. The perception of lung cancer risk had less influence than age and socio-economic category on the participation in screening. Finally, stigma did not appear to be a barrier to undergoing screening.
Conclusion
Active and former smokers were generally optimistic about screening; however, active smokers showed less inclination to participate in screening compared to former smokers and non-smokers. Three main factors appeared to influence this participation: the perception of the risk of developing cancer, age and socio-economic category.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference34 articles.
1. Institut National du cancer (INCa). Le cancer du poumon - Les cancers les plus fréquents [en ligne]. 2022. https://www.e-cancer.fr/Professionnels-de-sante/Les-chiffres-du-cancer-en-France/Epidemiologie-des-cancers/Les-cancers-les-plus-frequents/Cancer-du-poumon. Accessed 6 Sept 2022.
2. Rosell R, González-Cao M. Ablating lung cancer, knowing the tumor better. The Lancet Regional Health – Europe. 2022;22:100494.
3. Bichsel N. La stigmatisation: un problème fréquent aux conséquences multiples. Rev Méd Suisse. 2017;13:478–81. https://www.revmed.ch/view/436968/3748571/RMS_551_478.pdf. Accessed 6 Sept 2022.
4. Dubin RE, Kaplan A, Graves L, Ng VK. Reconnaître la stigmatisation. Sa présence dans les soins aux patients et dans la formation médicale. Can Fam Physician. 2017;63(12):913–5.
5. Chambers SK, Dunn J, Occhipinti S, et al. A systematic review of the impact of stigma and nihilism on lung cancer outcomes. BMC Cancer. 2012;12:184. https://doi.org/10.1186/1471-2407-12-184.